Customer Center
Login | Register


Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Read More


Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® Technology. Click here to start the conversation now.

Learn More


Luminex® Blog

When to Launch an LDT: Key Factors to Consider

According to an MLO article, cost is just one element in a complex decision

A new article in Medical Laboratory Observer offers a practical look at the factors to consider when deciding whether to design a new laboratory-developed test or choose a send-out reference lab test or an in vitro diagnostic.

Continue Reading >

xMAP® Technology Overview

Luminex xMAP® Technology Overview


xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.

Watch more videos >

Luminex on Twitter

When does it make sense to build your own test? We share our tips to help ease the decision-making with…
h J R
Did you hear? We started the clinical trials for VERIGENE II Gastrointestinal Assay, the first of many IVD assay cl…
h J R
When 3 people became ill at a Colorado county fair, rapid molecular testing with the #VERIGENE system identified…
h J R

Latest News

May 7
Luminex Corporation Reports First Quarter 2018 Financial Results

April 16
Luminex Corporation First Quarter Earnings Release Scheduled for May 7, 2018

March 8
Luminex Corporation to Present at the Barclays Global Healthcare Conference

February 12
Luminex Corporation Reports Fourth Quarter and Full-Year 2017 Financial Results

February 6
Luminex Corporation To Present At LEERINK Partners 7th Annual Global Healthcare Conference


May 28 – June 2
Malmo, Sweden

APHL Annual Meeting
June 2-4
Pasadena, CA

PSI Annual Meeting
June 3-6
Beurs Van Berlage, Amsterdam

ASM Microbe 2018
June 7-11
Atlanta, GA

Drug Discovery Summit
June 7-8
Berlin, Germany